Gaming and Leisure Properties Inc. Common Stock vs Organon & Co. Common Stock — how do they compare? Gaming and Leisure Properties Inc. Common Stock trades at $38.13 (market cap $11.15B), while Organon & Co. Common Stock trades at $13.58 (market cap $3.62B). The key difference: Gaming and Leisure Properties Inc. Common Stock is far larger — about 3.1× Organon & Co. Common Stock's market cap, and Gaming and Leisure Properties Inc. Common Stock pays the higher dividend (8.56%). Which is the better fit depends on your goals — on Pluang, investors hold Gaming and Leisure Properties Inc. Common Stock for 0 Days and Organon & Co. Common Stock for 0 Days on average.
| GLPI | OGN | |
|---|---|---|
Market Cap | $11.15B | $3.62B |
Volume | 1,865,490 | 2,892,999 |
Sector | Real Estate | Health |
52-Week High | $49.82 | $13.81 |
52-Week Low | $37.59 | $5.70 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $19.21B | $11.04B |
Dividend Yield | 8.56% | 0.58% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Gaming and Leisure Properties Inc. is a real estate investment trust that acquires, finances, and owns casino and gaming properties, which it leases to gaming operators under triple-net lease arrangements. It was the first publicly traded REIT focused on the gaming real estate sector in North America.
Read more on GLPI →Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →